As the world progressively recovers from the acute stages of the coronavirus disease 2019 (COVID-19) pandemic, we may be facing new challenges regarding the long-term …
B Liao, Z Liu, L Tang, L Li, Q Gan, H Shi… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Rationale: Previous studies of coronavirus disease 2019 (COVID-19) were mainly focused on cross-sectional analysis. In this study, we sought to evaluate the dynamic changes of …
A Peddapalli, M Gehani, AM Kalle, SR Peddapalli… - Viruses, 2021 - mdpi.com
The immunological findings from autopsies, biopsies, and various studies in COVID-19 patients show that the major cause of morbidity and mortality in COVID-19 is excess immune …
A Lebedeva, I Molodtsov, A Anisimova… - International journal of …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is characterized by immune activation in response to viral spread, in severe cases leading to the development of cytokine storm syndrome (CSS) …
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The …
J Marcinkiewicz, H Mazurek, G Majka… - … = Polish Archives of …, 2020 - ruj.uj.edu.pl
POLISH ARCHIVES OF INTERNAL MEDICINE 2020; 130 (10) 920 no symptoms or develop mild disease; death is rare and most often associated with oral corti costeroid administration …
J Marcinkiewicz, JM Witkowski… - Central European Journal …, 2021 - termedia.pl
COVID-19 is a highly contagious respiratory disease caused by the novel coronavirus SARS- CoV-2. Since October 2020 the second wave of the pandemic has been observed around …
J Niu, H Chen, K Chen, Y Liu, F Ju, T Xue, D Yin, C Li… - Medicine, 2020 - journals.lww.com
Background: We aimed to conduct a meta-analysis to assess the effect of pharmaceutical care on the treatment of coronavirus disease 2019 (COVID-19). Methods: All case-controlled …
Y Zhao, L Sui, P Wu, W Wang, G Tan, Z Wang, Y Yu… - bioRxiv, 2021 - biorxiv.org
The recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing global pandemic of COVID-19, may trigger …